Viewing Study NCT04603651


Ignite Creation Date: 2025-12-24 @ 11:55 PM
Ignite Modification Date: 2025-12-25 @ 9:51 PM
Study NCT ID: NCT04603651
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2023-10-02
First Post: 2020-10-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module